Short Summary
Foleon’s request for Director review to impose an adverse judgment on Turtl Surf & Immerse was denied. The Patent Owner argued procedural impropriety and reliance on established PTAB precedent rejecting adverse judgments after a disclaimer.
Detailed Summary
In response to FoLeon's request for Director review of the institution decision in IPR2025-01525, Turtl Surf & Immerse Limited, represented by Matthew A. Argenti, contended that the petitioner failed to preserve the issue of adverse judgment, offered no permissible basis for review, and that PTAB precedent—including General Electric and multiple subsequent decisions—consistently declines to enter adverse judgments after a pre‑institution disclaimer. Citing case law and emphasizing efficient Office administration, the Patent Owner urged denial of the Director review, a position the Director ultimately upheld.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Foleon Inc. et al. vs TURTL SURF & IMMERSE LIMITED is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck has filed a Post‑Grant Review petition challenging Halozyme’s U.S. Patent 12,104,185 covering modified PH20 hyaluronidase proteins. The petition argues the claims are overly broad, lack written description and enablement, and are obvious in view of prior art. The case is pending institution.
Apple Inc.vsApex Beam Technologies LLC
Apple has filed an IPR petition challenging Apex Beam’s 2019 patent covering paging methods in LTE/5G networks, asserting that all 20 claims are obvious over prior‑art standards and patents. The petition seeks institution of the review and argues that discretionary denial is unwarranted.
X Corp.vsSterling Computers Corporation
X Corp. petitions the PTAB to invalidate Sterling Computers’ 7,716,217 patent covering email relevance scoring, asserting that all 22 claims are obvious over prior art such as Dumais, Kircher, Krug, and Marston. The petition also argues that discretionary denial is unwarranted.
Texas Instruments IncorporatedvsGreenthread, LLC
The PTAB granted Director Review of the Final Written Decisions in Texas Instruments’ IPRs against Greenthread, vacated those decisions, and remanded the cases for further proceedings, ordering new discovery on the privity issue.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Halozyme has sought a Director Review of the PGR, and Merck has 5 business days to file a brief response without new evidence.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.